Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

U.S. stocks fall mildly, amid soft GDP data for the third quarter

Published 10/29/2015, 04:14 PM
Updated 10/29/2015, 04:32 PM
The Dow, NASDAQ and the S&P 500 all fell slightly on Thurs.
US500
-
DJI
-
INTC
-
VRTX
-
AAPL
-
PFE
-
AGN_pa
-
FFIV
-
IXIC
-
CHTR
-
HBI
-

Investing.com -- U.S. stocks fell mildly on Thursday erasing some of their gains from Wednesday's surge, following the release of soft GDP for the third quarter data earlier in the session.

After rallying late in Wednesday's session following hawkish comments by the Federal Reserve on a potential December interest rate hike, the Dow Jones Industrial Average and NASDAQ Composite index inched down on Thursday. The Dow lost 23.72 or 0.13% to 17,755.80 in Thursday's session, one day after surging more than 200 points. The NASDAQ, meanwhile, dipped 21.42 or 0.42% to close at 5,074.27. The major indices are still on pace for a record month with one trading day left in October.

On the S&P 500 Composite index, seven of 10 sectors closed in the red, as it lost 0.94 or 0.04% to end the session at 2,089.41. Stocks in the Technology and the Utilities sectors lagged, each falling by more than 0.5% on the session. Stocks in the Consumer Services, Health Care and Energy industries led.

The top performer on the Dow was Apple Inc (O:AAPL), which gained 1.26 or 1.06% to 120.53. Investors continue to digest strong quarterly earning by the world's largest company earlier this week when Apple (O:AAPL) recorded record fourth-quarter iPhone sales. The worst performer was INTC, which lost nearly 2% to 34.03.

Intel (O:INTC) finished just below Pfizer Inc (N:PFE), which fell 1.92% to 34.77. Earlier, shares in Pfizer and Allergan (N:AGN_pa) were halted after both companies confirmed they are engaged in preliminary talks. The acquisition could create one of the largest pharmaceutical companies on record. Allergan shares surged nearly 6% to 304.38.

The biggest gainer on the NASDAQ was Vertex Pharmaceuticals Inc (O:VRTX), which gained more than 5% to 126.17. Vertex Pharmaceuticals (O:VRTX) finished just above Charter Communications Inc (O:CHTR), after the cable operator reported robust net earnings last quarter. Charter and Time Warner expect to complete a long-awaited merger in the first quarter of 2016. The worst performer was NXP Semiconductors after it lowered its revenue outlook for the final quarter of the year. NXP Semiconductors, the top chip supplier for Apple iPhone 6 products, plunged 17.92 or 19.71% to 73.00.

The top performer on the S&P 500 was Hanesbrands Inc (N:HBI), which soared 3.96 or 14.35% to 31.56 after posting double-digit revenue growth during the company's third quarter. The worst performer was F5 Networks Inc (O:FFIV), after the application delivery networking technology company reported worse than expected earnings on the quarter. Shares in F5 Networks (O:FFIV) plummeted 11.09 or 14.35% to 31.56.

On the New York Stock Exchange, declining issues outnumbered advancing ones by a 1,919 to 1,166 margin.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.